Half-year report · Q2
4480.TEDINET S100WJ2N
Period2025-01-01 → 2025-06-30
Filed2025-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥18.5bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥29.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Operating income | ¥1.5bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | ¥2.3bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.1bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.8bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥647m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥647m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | ¥2.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥47.4bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥45.2bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥42.2bn | at 2024-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥29.4bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥25.0bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥18.1bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.2bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.5bn | at 2024-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.5bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥19.0bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.5bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥19.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.4bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.9bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.4bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.5bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥6.3bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.7bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥8.2bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥11.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥11.1bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥20.05 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.17 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.9 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥19.95 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥85.62 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.5 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 38.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.1% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥2.9bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥4.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥4.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥51m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥589m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥589m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥349m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥4.4bn |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥2.2bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥43m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥239m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥239m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥132m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥2m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥14.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥14.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥4.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 534
| Item | Context | Value | Unit |
|---|---|---|---|
| Income before income taxes | CurrentYTDDuration | 1779000000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 327000000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 530000000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 283000000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 618000000 | JPY |
| Amortization of security deposit ope cf | Prior1YTDDuration | 6000000 | JPY |
| Amortization of security deposit ope cf | CurrentYTDDuration | 12000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | 10000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | 1000000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | 0 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -8000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 18000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 88000000 | JPY |
| Amortization of stock issuance cost ope cf | Prior1YTDDuration | 5000000 | JPY |
| Amortization of stock issuance cost ope cf | CurrentYTDDuration | － | JPY |
| Settlement received ope cf | Prior1YTDDuration | -1163000000 | JPY |
| Settlement received ope cf | CurrentYTDDuration | -270000000 | JPY |
| Gain on sales of non current assets ope cf | Prior1YTDDuration | -2000000 | JPY |
| Gain on sales of non current assets ope cf | CurrentYTDDuration | － | JPY |
| Loss on sales of non current assets ope cf | Prior1YTDDuration | － | JPY |
| Loss on sales of non current assets ope cf | CurrentYTDDuration | 1000000 | JPY |
| Loss on abandonment of noncurrent assets ope cf | Prior1YTDDuration | － | JPY |
| Loss on abandonment of noncurrent assets ope cf | CurrentYTDDuration | 0 | JPY |
| Gain on sale of shares of subsidiaries and associates ope cf | Prior1YTDDuration | － | JPY |
| Gain on sale of shares of subsidiaries and associates ope cf | CurrentYTDDuration | -155000000 | JPY |
| Gain on sale of businesses ope cf | Prior1YTDDuration | － | JPY |
| Gain on sale of businesses ope cf | CurrentYTDDuration | -48000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -433000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 115000000 | JPY |
| Decrease increase in accounts receivable other ope cf | Prior1YTDDuration | -126000000 | JPY |
| Decrease increase in accounts receivable other ope cf | CurrentYTDDuration | 41000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | 40000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -52000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 44000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -92000000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | 359000000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | 316000000 | JPY |
| Increase decrease in accrued expenses ope cf | Prior1YTDDuration | 74000000 | JPY |
| Increase decrease in accrued expenses ope cf | CurrentYTDDuration | -211000000 | JPY |
| Increase decrease in contract liabilities ope cf | Prior1YTDDuration | -35000000 | JPY |
| Increase decrease in contract liabilities ope cf | CurrentYTDDuration | -85000000 | JPY |
| Increase decrease in deposits received ope cf | Prior1YTDDuration | 57000000 | JPY |
| Increase decrease in deposits received ope cf | CurrentYTDDuration | 104000000 | JPY |
| Other net ope cf | Prior1YTDDuration | 195000000 | JPY |
| Other net ope cf | CurrentYTDDuration | -193000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 2833000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 2492000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 0 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 9000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -18000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |